Women with mechanical heart valves require anticoagulation during pregnancy in order to prevent thromboembolic events, but each drug regimen risks harming either the mother or fetus. Now, a new ...
LOS ANGELES -- Survival outcomes favored mechanical valves for isolated surgical aortic valve replacement (SAVR) for people until age 60, after which a tissue valve may start to have an advantage, ...
LOS ANGELES, CA—In patients ages 60 years or younger undergoing surgical aortic valve replacement, mechanical valves are associated with a survival benefit compared with bioprosthetic valves, ...
Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research has found. Patients aged between 50 ...
LOS ANGELES—January 25, 2025—A late-breaking study presented today at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide ...
Direct oral anticoagulants were associated with lower risks of ischemic stroke or systemic embolism and bleeding compared with warfarin. The study included patients with atrial fibrillation (AF) and ...
Choosing the optimal aortic valve prosthesis for middle-aged patients (late 40s to early 60s) with aortic stenosis presents a challenge. The available options all have substantial drawbacks that must ...
Anticoagulation management in pregnant women with mechanical heart valves represents a complex clinical challenge that necessitates a delicate balance between reducing maternal thromboembolic risk and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback